This collaboration is focused on advancing the design of the MACH-1 System, preparing it for Phase 1 clinical trials.
Read More
On May 10, Product Creation Studio and Life Science Washington hosted DeviceConnect to discuss the rapid evolution of modern medicine, spurred by incredible advancements in vaccine and drug delivery. Featuring panelists with expertise ranging from pharmaceutical therapeutics to biotechnology to thermostable formulations of vaccines, the discussion enlightened the audience on emerging trends and the global impact on both patients and providers.
Read More
As new treatment modalities emerge, we’re no longer operating under a “business as usual” where patients simply pop a pill or receive an injection. Personalized medicine, gene therapies, and novel delivery mechanisms are paving the way for an innovative era in medical device design.
Read More